Clinical tricuspid stenosis has not previously been reported in patients with systemic lupus erythematosus (SLE). A 25 year old woman with active SLE presented with signs of severe right ventricular failure. Cardiac catheterisation confirmed the diagnosis of tricuspid stenosis and regurgitation together with mitral regurgitation. This patient underwent successful tricuspid and mitral valve replacement.
It is well established from necropsy studies that cardiac manifestations of systemic lupus erythematosus (SLE) may involve the endocardium, myocardium, pericardium, heart valves, and coronary vessels.' The endocardial involvement described by Libman Mandell'0 reviewed 20 haemodynamically significant valvular lesions reported in patients with SLE and found that aortic regurgitation, mitral regurgitation, mitral stenosis, and mixed mitral lesions were common, with tricuspid regurgitation without stenosis present in only one patient.
Libman and Sacks2 found tricuspid valve involvement in necropsy studies; Laufer et al" described tricuspid valve replacement for severe tricuspid regurgitation in a 9 year old patient.
A survey of reported work has shown that 22 patients with SLE have undergone valve replacement. Three of these have had multiple replacements, SLE being present in most patients for 7-10 years; the mitral valve was the most frequently affected.'2 Our patient is therefore only the fourth with SLE to undergo multiple replacement. She had pericarditis, found during surgery, mitral regurgitation, and severe tricuspid stenosis with regurgitation, which required two valve replacements for disease attributable to lupus endocarditis. This combination, we believe, has not been reported previously.
Thanks are due to Dr Eckhart Olsen of the National Heart Hospital for advice.
